Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
REVOLUTIOn: Antivirals for Hospitalized COVID-19
NCT04468087Phase 3Completed
- Sponsor
- HCor
- Start
- Feb 2021
- Primary completion
- Aug 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of atazanavir, daclatasvir, sofosbuvir in coronavirus disease 2019 (COVID-19), sponsored by HCor. Started Feb 2021; status: completed.
02
Drugs
atazanavirdaclatasvirsofosbuvir
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04468087.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04468087.